Clinical Trial Update: BMAC Enhanced Coronary Artery Bypass Grafting (CABG) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating bone marrow aspirate concentrate (BMAC) enhanced CABG for congestive heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Bone marrow aspirate concentrate (BMAC) enhanced CABG (bone marrow aspirate concentrate)

Snippet

Sponsor: Harvest Technologies | Conditions: Congestive Heart Failure | Phase 1, Phase 2 | Status: TERMINATED